(function(){
			var content_array=["<p><strong>About China Cord Blood Corporation<\/strong><\/p>\r\n<p>China Cord Blood Corporation is the first and largest umbilical cord  blood  banking operator in China in terms of geographical coverage and  the only cord  blood banking operator with multiple licenses. Under  current PRC government  regulations, only one licensed cord blood  banking operator is permitted to  operate in each licensed region and  only seven licenses have been authorized as  of today. China Cord Blood  Corporation provides cord blood collection,  laboratory testing,  hematopoietic stem cell processing and stem cell storage  services. For  more information, please visit our website at <a href=\"http:\/\/www.chinacordbloodcorp.com\/\" target=\"_blank\">http:\/\/www.chinacordbloodcorp.com\/<\/a>.<\/p>\r\n<p><strong>Safe Harbor Statement <\/strong><\/p>\r\n<p>This press release contains forward-looking statements within the  meaning of  Section 27A of the Securities Act of 1933, and Section 21E  of the Securities  Exchange Act of 1934. These statements relate to  future events or the Company's  future financial performance. The  Company has attempted to identify  forward-looking statements by  terminology including \"anticipates\", \"believes\",  \"expects\", \"can\",  \"continue\", \"could\", \"estimates\", \"intends\", \"may\", \"plans\",   \"potential\", \"predict\", \"should\" or \"will\" or the negative of these  terms or  other comparable terminology. These statements are only  predictions;  uncertainties and other factors may cause the Company's  actual results, levels  of activity, performance or achievements to be  materially different from any  future results, levels of activity,  performance or achievements expressed or  implied by these  forward-looking statements. The information in this press  release is  not intended to project future performance of the Company. Although  the  Company believes that the expectations reflected in the forward-looking   statements are reasonable, the Company does not guarantee future  results, levels  of activity, performance or achievements. The Company  expectations are as of the  date of this press release, and the Company  does not intend to update any of the  forward-looking statements after  the date of this press release to conform these  statements to actual  results, unless required by law.<\/p>\r\n<p>The forward-looking statements included in this press release are  subject to  risks, uncertainties and assumptions about the Company's  businesses and business  environments. These statements reflect the  Company's current views with respect  to future events and are not a  guarantee of future performance. Actual results  of the Company's  operations may differ materially from information contained in  the  forward-looking statements as a result of risk factors some of which   include, among other things: continued compliance with government  regulations  regarding cord blood banking in the People's Republic of  China, or PRC and any  other jurisdiction in which the Company conducts  its operations; changing  legislation or regulatory environments in the  PRC and any other jurisdiction in  which the Company conducts its  operations; the acceptance by subscribers of the  Company's different  pricing and payment options and reaction to the introduction  of the  Company's premium-quality pricing strategy; demographic trends in the   regions of the PRC in which the Company is the exclusive licensed cord  blood  banking operator; labor and personnel relations; the existence of  a significant  shareholder able to influence and direct the corporate  policies of the Company;  credit risks affecting the Company's revenue  and profitability; changes in the  healthcare industry, including those  which may result in the use of stem cell  therapies becoming redundant  or obsolete; the Company's ability to effectively  manage its growth,  including implementing effective controls and procedures and  attracting  and retaining key management and personnel; changing interpretations   of generally accepted accounting principles; the availability of capital   resources, including in the form of capital markets financing  opportunities, in  light of industry developments affecting issuers that  have pursued a \"reverse  merger\" with an operating company based in  China, as well as general economic  conditions; compliance with  restrictive debt covenants under our senior  convertible notes; and  other relevant risks detailed in the Company's filings  with the  Securities and Exchange Commission in the United States.<\/p>\r\n<p>This announcement contains translations of certain Renminbi amounts  into U.S.  dollars at specified rates solely for the convenience of  readers. Unless  otherwise noted, all translations from Renminbi to U.S.  dollars as of and for  the periods ending June 30, 2013 were made at  the noon buying rate of RMB6.1374  to $1.00 on June 28, 2013 in the City  of New York for cable transfers in  Renminbi per U.S. dollar as  certified for customs purposes by the Federal  Reserve Bank of New York.  China Cord Blood Corporation makes no representation  that the Renminbi  or U.S. dollar amounts referred to in this press release could  have  been or could be converted into U.S. dollars or Renminbi, at any  particular  rate or at all.<\/p>\r\n<p><strong>For more information, please contact:<\/strong><\/p>\r\n<p>China Cord Blood Corporation<br \/>Investor Relations Department<br \/>Tel: (+852)  3605-8180<br \/>Email: <a href=\"mailto:ir@chinacordbloodcorp.com\" target=\"_blank\">ir@chinacordbloodcorp.com<\/a> &nbsp;<\/p>\r\n<p>ICR, Inc.<br \/>Mr. William Zima<br \/>Tel: (+86) 10-6583-7511<br \/>U.S. Tel: (646)  405-5185<br \/>Email: <a href=\"mailto:William.Zima@icrinc.com\" target=\"_blank\">William.Zima@icrinc.com<\/a><\/p>"];
			$("#dvExtra").html(content_array[0]);})();